S100A4 and cancer: S100A4 advances the formation of PMNs and builds a microenvironment suitable for the survival of malignant tumors, while an S100A4 siRNA (siS100A4) blocks the expression of S100A4 and inhibits tumor growth (Liu et al., 2018; van den Brand et al., 2018).